Ultrafine particles affect the balance of endogenous pro- and anti-inflammatory lipid mediators in the lung: in-vitro and in-vivo studies

Particle and Fibre Toxicology

Volumn 9, Issue , 2012, Pages

  Beck Speier, Ingrid ^a   Karg, Erwin ^a   Behrendt, Heidrun ^b,c   Stoeger, Tobias ^a   Alessandrini, Francesca ^a,b,c  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Christine Kuehne Center for Allergy Research and Education (CK CARE)   (Germany)

Author keywords

Allergy; Inflammation; Lipid mediators; Particulate matter

Indexed keywords

5 HYDROXYICOSATETRAENOIC ACID; 8 ISOPROSTANE; CARBON; LEUKOTRIENE B4; LIPOXIN A; PROSTAGLANDIN E2; ULTRAFINE CARBON PARTICLE; UNCLASSIFIED DRUG;

AIRBORNE PARTICLE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; EXPOSURE; FEMALE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUNG ALVEOLUS CELL; LUNG ALVEOLUS MACROPHAGE; LUNG PARENCHYMA; MEDIATOR; MOUSE; NONHUMAN; OXIDATIVE STRESS; PARTICLE SIZE; PRIORITY JOURNAL; RAT; RESPIRATORY TRACT INFLAMMATION; SENSITIZATION;

ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; CARBON; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; INFLAMMATION MEDIATORS; INHALATION EXPOSURE; LIPID PEROXIDATION; LUNG; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; OVALBUMIN; PARTICLE SIZE; PARTICULATE MATTER; PULMONARY ALVEOLI; RATS; RATS, INBRED WKY;

MUS; RATTUS;

EID: 84870279375     PISSN: None     EISSN: 17438977     Source Type: Journal    
DOI: 10.1186/1743-8977-9-27     Document Type: Article

References (50)

1. Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol 2005, 6(12):1191-1197. 10.1038/ni1276, 16369558.
2. Vancheri C, Mastruzzo C, Sortino MA, Crimi N. The lung as a privileged site for the beneficial actions of PGE2. Trends Immunol 2004, 25(1):40-46. 10.1016/j.it.2003.11.001, 14698283.
3. Islam SA, Thomas SY, Hess C, Medoff BD, Means TK, Brander C, Lilly CM, Tager AM, Luster AD. The leukotriene B4 lipid chemoattractant receptor BLT1 defines antigen-primed T cells in humans. Blood 2006, 107(2):444-453. 10.1182/blood-2005-06-2362, 1490027, 16179368.
4. Cho KJ, Seo JM, Shin Y, Yoo MH, Park CS, Lee SH, Chang YS, Cho SH, Kim JH. Blockade of airway inflammation and hyperresponsiveness by inhibition of BLT2, a low-affinity leukotriene B4 receptor. Am J Respir Cell Mol Biol 2010, 42(3):294-303. 10.1165/rcmb.2008-0445OC, 19448154.
5. Harizi HM, Juzan V, Pitard J, Moreau F, Gualde N. Cyclooxygenase-2-issued prostaglandin e(2) enhances the production of endogenous IL-10, which down-regulates dendritic cell functions. J Immunol 2002, 168(5):2255-2263.
6. Kohli P, Levy BD. Resolvins and protectins: mediating solutions to inflammation. Br J Pharmacol 2009, 158(4):960-971. 10.1111/j.1476-5381.2009.00290.x, 2785519, 19594757.
7. Bonnans C, Levy BD. Lipid mediators as agonists for the resolution of acute lung inflammation and injury. Am J Respir Cell Mol Biol 2007, 36(2):201-205. 2176108, 16990613.
8. Bochner BS, Busse WW. Allergy and asthma. J Allergy Clin Immunol 2005, 115(5):953-959. 10.1016/j.jaci.2005.02.032, 15867851.
9. Moorman JE, Rudd RA, Johnson CA, King M, Minor P, Bailey C, Scalia MR, Akinbami LJ. National surveillance for asthma-United States, 1980-2004. MMWR Surveill Summ 2007, 56(8):1-54.
10. Holgate ST, Polosa R. Treatment strategies for allergy and asthma. Nat Rev Immunol 2008, 8(3):218-230. 10.1038/nri2262, 18274559.
11. Dockery DW, Brunekreef B. Longitudinal studies of air pollution effects on lung function. Am J Respir Crit Care Med 1996, 154(6 Pt 2):S250-S256.
12. Pope CA, Bates DV, Raizenne ME. Health effects of particulate air pollution: time for reassessment?. Environ Health Perspect 1995, 103(5):472-480. 10.1289/ehp.95103472, 1523269, 7656877.
13. Schwartz J, Slater D, Larson TV, Pierson WE, Koenig JQ. Particulate air pollution and hospital emergency room visits for asthma in Seattle. Am Rev Respir Dis 1993, 147(4):826-831.
14. Andersen ZJ, Wahlin P, Raaschou-Nielsen O, Ketzel M, Scheike T, Loft S. Size distribution and total number concentration of ultrafine and accumulation mode particles and hospital admissions in children and the elderly in Copenhagen, Denmark. Occup Environ Med 2008, 65(7):458-466. 10.1136/oem.2007.033290, 17989204.
15. Penttinen PK, Timonen L, Tiittanen P, Mirme A, Ruuskanen J, Pekkanen J. Ultrafine particles in urban air and respiratory health among adult asthmatics. Eur Respir J 2001, 17(3):428-435. 10.1183/09031936.01.17304280, 11405521.
16. Peters A, Wichmann HE, Tuch T, Heinrich J, Heyder J. Respiratory effects are associated with the number of ultrafine particles. Am J Respir Crit Care Med 1997, 155(4):1376-1383.
17. Oberdorster G, Oberdorster E, Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 2005, 113(7):823-839. 10.1289/ehp.7339, 1257642, 16002369.
18. Schmid O, Moller W, Semmler-Behnke M, Ferron GA, Karg E, Lipka J, Schulz H, Kreyling WG, Stoeger T. Dosimetry and toxicology of inhaled ultrafine particles. Biomarkers 2009, 14(Suppl 1):67-73.
19. Kreyling WG, Semmler-Behnke M, Moller M. Ultrafine particle-lung interactions: does size matter?. J Aerosol Med 2006, 19(1):74-83. 10.1089/jam.2006.19.74, 16551218.
20. Lighty JS, Veranth JM, Sarofim AF. Combustion aerosols: factors governing their size and composition and implications to human health. J Air Waste Manag Assoc 2000, 50(9):1565-1618. discussion 1619-22, 10.1080/10473289.2000.10464197, 11055157.
21. Alessandrini F, Schulz H, Takenaka S, Lentner B, Karg E, Behrendt H, Jakob T. Effects of ultrafine carbon particle inhalation on allergic inflammation of the lung. J Allergy Clin Immunol 2006, 117(4):824-830. 10.1016/j.jaci.2005.11.046, 16630940.
22. Alessandrini F, Beck-Speier I, Krappmann D, Weichenmeier I, Takenaka S, Karg E, Kloo B, Schulz H, Jakob T, Mempel M, Behrendt H. Role of Oxidative Stress in Ultrafine Particle-Induced Exacerbation of Allergic Lung Inflammation. Am J Respir Crit Care Med 2009, 179(11):984-991. 10.1164/rccm.200807-1061OC, 19264975.
23. Beck-Speier I, Dayal N, Karg E, Maier KL, Schumann G, Schulz H, Semmler M, Takenaka S, Stettmaier K, Bors W, Ghio A, Samet JM, Heyder J. Oxidative stress and lipid mediators induced in alveolar macrophages by ultrafine particles. Free Radic Biol Med 2005, 38(8):1080-1092. 10.1016/j.freeradbiomed.2005.01.004, 15780766.
24. Roth C, Ferron G, Karg E, Lentner B, Schumann G, Takenaka S, Heyder J. Generation of ultrafine particles by spark discharging. Aerosol Sci Techn 2004, 38:228-235.
25. Beck-Speier I, Kreyling WG, Maier KL, Dayal N, Schladweiler MC, Mayer P, Semmler-Behnke M, Kodavanti UP. Soluble iron modulates iron oxide particle-induced inflammatory responses via prostaglandin E(2)synthesis: In vitro and in vivo studies. Part Fibre Toxicol 2009, 6:34. 10.1186/1743-8977-6-34, 2806337, 20028532.
26. Beck-Speier I, Dayal N, Karg E, Maier KL, Schumann G, Semmler M, Koelsch SM. Oxymetazoline inhibits proinflammatory reactions: effect on arachidonic acid-derived metabolites. J Pharmacol Exp Ther 2006, 316(2):843-851.
27. Alessandrini F, Ziesenis A, Takenaka S, Karg E, Heyder J, Ring J, Behrendt H. Effects of inhaled CdO particles on the sphingolipid synthesis of rat lungs. Inhal Toxicol 2003, 15(4):343-356. 10.1080/08958370304457, 12635003.
28. Peters A, Dockery DW, Heinrich J, Wichmann HE. Short-term effects of particulate air pollution on respiratory morbidity in asthmatic children. Eur Respir J 1997, 10(4):872-879.
29. Su DS, Jentoft RE, Müller JO, Rothe D, Jacob E, Simpson CD, Tomovic Z, Müllen K, Messerer A, Pöschl U, Niessner, Schlögl R. Microstructure and oxidation behavior of Euro IV diesel engine soot: a comparative study with synthetic model soot substances. Catal Today 2004, 90:127-132.
30. Wentzel M, Gorzawski H, Naumann KH, Saathoff H, Weinbruch S. Transmission electron microscopical and aerosol dynamical characterization of soot aerosols. Aerosol Science 2003, 34:1347-1370.
31. Beck-Speier I, Dayal N, Karg E, Maier KL, Roth C, Ziesenis A, Heyder J. Agglomerates of ultrafine particles of elemental carbon and TiO2 induce generation of lipid mediators in alveolar macrophages. Environ Health Perspect 2001, 109(Suppl 4):613-618. 1240591, 11544173.
32. Anjilvel S, Asharian B, Freijer J, Subramaniam R. Multiple path particle deposition model version 1.11 1999, Bilthoven, The Nederlands: National Institute of Public Health.
33. Stone KC, Mercer RR, Gehr P, Stockstill B, Crapo JD. Allometric relationships of cell numbers and size in the mammalian lung. Am J Respir Cell Mol Biol 1992, 6(2):235-243.
34. Takenaka S, Karg E, Kreyling WG, Lentner B, Moller W, Behnke-Semmler M, Jennen L, Walch A, Michalke B, Schramel P, Heyder J, Schulz H. Distribution pattern of inhaled ultrafine gold particles in the rat lung. Inhal Toxicol 2006, 18(10):733-740. 10.1080/08958370600748281, 16774862.
35. Beck-Speier I, Oswald B, Maier KL, Karg E, Ramseger R. Oxymetazoline inhibits and resolves inflammatory reactions in human neutrophils. J Pharmacol Sci 2009, 110(3):276-284. 10.1254/jphs.09012FP, 19609065.
36. Serhan CN. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol 2007, 25:101-137. 10.1146/annurev.immunol.25.022106.141647, 17090225.
37. Denzlinger C. Biology and pathophysiology of leukotrienes. Crit Rev Oncol Hematol 1996, 23(3):167-223. 10.1016/1040-8428(96)00205-3, 8842590.
38. Alessandrini F, Weichenmeier I, van Miert E, Takenaka S, Karg E, Blume C, Mempel M, Schulz H, Bernard A, Behrendt H. Effects of ultrafine particles-induced oxidative stress on Clara cells in allergic lung inflammation. Part Fibre Toxicol 2010, 7:11. 10.1186/1743-8977-7-11, 2880284, 20420656.
39. Shimizu T. Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation. Annu Rev Pharmacol Toxicol 2009, 49:123-150. 10.1146/annurev.pharmtox.011008.145616, 18834304.
40. Harris SG, Padilla J, Koumas L, Ray D, Phipps RP. Prostaglandins as modulators of immunity. Trends Immunol 2002, 23(3):144-150. 10.1016/S1471-4906(01)02154-8, 11864843.
41. Haworth O, Levy BD. Endogenous lipid mediators in the resolution of airway inflammation. Eur Respir J 2007, 30(5):980-992. 10.1183/09031936.00005807, 3005702, 17978156.
42. Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN. Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol 2001, 2(7):612-619. 10.1038/89759, 11429545.
43. Fukunaga K, Kohli P, Bonnans C, Fredenburgh LE, Levy BD. Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury. J Immunol 2005, 174(8):5033-5039.
44. Martin JG, Suzuki M, Maghni K, Pantano R, Ramos-Barbon D, Ihaku D, Nantel F, Denis D, Hamid Q, Powell WS. The immunomodulatory actions of prostaglandin E2 on allergic airway responses in the rat. J Immunol 2002, 169(7):3963-3969.
45. Dimova-Yaneva D, Russell D, Main M, Brooker RJ, Helms PJ. Eosinophil activation and cysteinyl leukotriene production in infants with respiratory syncytial virus bronchiolitis. Clin Exp Allergy 2004, 34(4):555-558. 10.1111/j.1365-2222.2004.1918.x, 15080807.
46. Henderson WR, Tang LO, Chu SJ, Tsao SM, Chiang GK, Jones F, Jonas M, Pae C, Wang H, Chi EY. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am J Respir Crit Care Med 2002, 165(1):108-116.
47. Holgate ST, Peters-Golden M, Panettieri RA, Henderson WR. Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. J Allergy Clin Immunol 2003, 111(1 Suppl):S18-S34. discussion S34-6.
48. Levy BD, Bonnans C, Silverman ES, Palmer LJ, Marigowda G, Israel E. Diminished lipoxin biosynthesis in severe asthma. Am J Respir Crit Care Med 2005, 172(7):824-830. 10.1164/rccm.200410-1413OC, 2718403, 15961693.
49. Bhavsar PK, Levy BD, Hew MJ, Pfeffer MA, Kazani S, Israel E, Chung KF. Corticosteroid suppression of lipoxin A4 and leukotriene B4 from alveolar macrophages in severe asthma. Respir Res 2010, 11:71. 10.1186/1465-9921-11-71, 2894769, 20529300.
50. Planaguma A, Kazani S, Marigowda G, Haworth O, Mariani TJ, Israel E, Bleecker ER, Curran-Everett D, Erzurum SC, Calhoun WJ, Castro M, Chung KF, Gaston B, Jarjour NN, Busse WW, Wenzel SE, Levy BD. Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma. Am J Respir Crit Care Med 2008, 178(6):574-582. 10.1164/rccm.200801-061OC, 2542432, 18583575.